Correlation Between Ionis Pharmaceuticals and CytomX Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ionis Pharmaceuticals and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ionis Pharmaceuticals and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ionis Pharmaceuticals and CytomX Therapeutics, you can compare the effects of market volatilities on Ionis Pharmaceuticals and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ionis Pharmaceuticals with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ionis Pharmaceuticals and CytomX Therapeutics.

Diversification Opportunities for Ionis Pharmaceuticals and CytomX Therapeutics

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ionis and CytomX is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Ionis Pharmaceuticals and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Ionis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ionis Pharmaceuticals are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Ionis Pharmaceuticals i.e., Ionis Pharmaceuticals and CytomX Therapeutics go up and down completely randomly.

Pair Corralation between Ionis Pharmaceuticals and CytomX Therapeutics

Given the investment horizon of 90 days Ionis Pharmaceuticals is expected to generate 6.93 times less return on investment than CytomX Therapeutics. But when comparing it to its historical volatility, Ionis Pharmaceuticals is 4.83 times less risky than CytomX Therapeutics. It trades about 0.01 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  288.00  in CytomX Therapeutics on August 31, 2024 and sell it today you would lose (182.00) from holding CytomX Therapeutics or give up 63.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.79%
ValuesDaily Returns

Ionis Pharmaceuticals  vs.  CytomX Therapeutics

 Performance 
       Timeline  
Ionis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ionis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
CytomX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CytomX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, CytomX Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Ionis Pharmaceuticals and CytomX Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ionis Pharmaceuticals and CytomX Therapeutics

The main advantage of trading using opposite Ionis Pharmaceuticals and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ionis Pharmaceuticals position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.
The idea behind Ionis Pharmaceuticals and CytomX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope